<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=314834185700910&amp;ev=PageView&amp;noscript=1">

New Update: Healthcare Costs Increasing by Over 60% in Some States. Will you be impacted?

Learn More

How Charles River Laboratories International Employees Can Avoid Costly Retirement Mistakes

image-table

Healthcare Provider Update: Healthcare Provider for Charles River Laboratories International Charles River Laboratories International, Inc. is primarily known for providing various preclinical and clinical laboratory services to the pharmaceutical, medical device, and biotechnology industries. Their healthcare offerings include specialized services such as toxicology testing, bioanalysis, and laboratory research, but they do not act as a traditional healthcare insurance provider or offer direct healthcare services. Potential Healthcare Cost Increases in 2026 In 2026, significant premium increases are anticipated for health insurance plans within the Affordable Care Act (ACA) marketplace, driven by escalating medical costs and the possible expiration of enhanced federal subsidies. Some states may see hikes exceeding 60%, particularly affecting low and middle-income families reliant on these plans. With reports indicating that over 90% of marketplace enrollees could face premium raises of 75% or more, the landscape for healthcare affordability will become increasingly challenging, prompting consumers and companies alike to reassess their healthcare strategies and financial planning. Click here to learn more

'Charles River Laboratories International employees should focus on long-term investment strategies that are grounded in historical performance rather than reacting to market trends or the allure of fleeting opportunities like gold or real estate, as these can lead to poor financial outcomes in retirement.' – Michael Corgiat, a representative of The Retirement Group, a division of Wealth Enhancement.

'Charles River Laboratories International employees can strengthen their retirement outlook by avoiding the common pitfall of buying high and selling low, instead embracing a disciplined, long-term approach to investing that prioritizes sound financial principles over market speculation.' – Brent Wolf, a representative of The Retirement Group, a division of Wealth Enhancement.

In this article, we will discuss:

  1. The pitfalls of overvaluing gold, real estate, and savings accounts in retirement planning.

  2. The risks associated with the common mistake of buying high and selling low.

  3. Strategies to make smarter long-term investment decisions to strengthen your financial outlook.

The most recent Gallup poll provides yet another concerning look at how many American investors, including those with Charles River Laboratories International, make retirement investment choices that could ultimately cost them a lot of money. For decades, countless investors have placed their financial future at risk by making ill-timed investments in assets such as real estate, savings accounts, or gold that are frequently volatile or fail to deliver long-term returns. Despite the age-old adage to avoid buying high and selling low, the most recent research indicates that many investors have not learned from their mistakes.

Gold: A Cautionary Tale

Depending on the state of the market, gold has been a recurrent trend in the financial sector, going up and down in value. Despite its inherent volatility, many investors appear to accept it as a long-term investment, particularly as its price rises. Gold is now regarded by 23% respondents as the best long-term investment, up from 14% only a few years ago, according to the most recent Gallup poll. The recent spike in gold prices, which hit a record high of $3,444 an ounce, is likely the cause of this increase. Historical evidence, however, presents a different image.

When gold hit its previous high in 2011, 34% of Gallup survey respondents said it was the best investment option. Over the following few years, however, the value of gold fell by almost 50%, leaving many investors with large losses. In actuality, gold, like many other assets, has the potential to be a bubble—its value can fluctuate significantly, putting investors at risk of purchasing at the peak and selling at a loss.

Gold is not the only metal that goes through this cycle of purchasing high and selling low. It exhibits the same pattern as other assets, such as stocks and real estate. The price swings of gold serve as a warning: chasing assets after they have already experienced a sharp increase in value might have devastating results, especially for Charles River Laboratories International employees looking to improve their financial outlook.

Misplaced Confidence in CDs and Savings Accounts

The pervasive notion that certificates of deposit (CDs) and savings accounts are sound long-term investments is one of the most concerning trends identified by Gallup's survey. These low-risk, low-return solutions were the top pick for long-term gain for 13% of respondents. There is a clear misinterpretation of how investments operate here.

These financial instruments have not historically produced sufficient long-term returns. In actuality, the S&P 500 has beaten short-term deposits in over 75% of five-year periods, 85% of 10-year periods, and more than 90% of 15-year periods since the 1920s. For example, over a 10-year period, the S&P 500 has, on average, tripled in value, yielding a 200% return. Conversely, throughout the same time span, CDs and savings accounts have only produced returns of 45% to 70%. Simply stated, it is unlikely that money held in a CD or savings account will grow at the pace required for a comfortable retirement, a key concern for Charles River Laboratories International employees nearing retirement.

The Stock Market: A Lost Chance

The relationship between the stock market and investors has also been troubling. According to Gallup's survey, even in bull markets, many are generally hesitant or completely skeptical about investing $1,000 in the stock market. One of the greatest strategies to build wealth over time has been the stock market, especially the S&P 500. The Dow Jones Industrial Average has risen from about 2,700 to about 42,800 since 1990. Public mood has, however, been especially positive at the wrong times, most notably in the late 1990s and right before the market crashed in 2007.

The time frame before January 2000, when 67% of Gallup respondents said they were confident in the stock market, is a revealing illustration. For those who had invested at the peak of the market, this was just before the dot-com bubble burst, wiping out a significant amount of value. The public has frequently expressed confidence about the stock market after it has already increased, only to be let down when the market corrects itself, despite this history. For Charles River Laboratories International employees, understanding this pattern is critical for making smarter investment choices.

The Most Overrated Investment Is Real Estate?

This year, 37% of respondents chose real estate as the 'best long-term investment,' continuing its 13-year trend at the top of the Gallup poll. Given the historical propensity of the property market to rise in value, this trend is not surprising. However, from a financial perspective, real estate has frequently performed worse than other investments.

Real estate has only increased in value at an average annual pace of 4.2% since the 1920s. Long-term returns from the stock market, gold, and even Treasury bonds are higher than this rate. Nonetheless, there are non-monetary advantages to property, such as the opportunity to live rent-free. Those who own their homes and are exempt from paying a landlord will find this especially alluring.

However, there are other expenses to take into account. The costs associated with owning, such as upkeep, property taxes, insurance, and real estate agents' fees, may reduce the returns. Additional expenses for rental properties include hiring a property manager and managing renters, some of whom may suddenly vacate or fall behind on their payments.

The leverage that real estate provides—buying a property with 20% down and borrowing the remaining 80%—is frequently linked to its allure. Real estate prices have increased in recent decades as home ownership has become more affordable due to declining mortgage rates. However, the benefit of leverage is lessened now that mortgage rates are higher than they were 20 years ago. Given the possibility of future price drops and the fact that housing costs are still at all-time highs, it is uncertain if real estate will continue to yield substantial returns. This uncertainty should be carefully considered by Charles River Laboratories International employees planning for retirement.

Purchasing High and Selling Low: The Risk

In the stock market, real estate, or gold, investors have frequently made the mistake of buying high and selling low. Many make the basic error of acting in this way. Real estate was the go-to investment during the height of the housing boom in 2000. However, the public abandoned the market when it crashed in 2008, at the same time that mortgage rates dropped and housing became more affordable. The gold market followed the same pattern, and the stock market is showing comparable patterns.

The takeaway from this is straightforward: rather than following trends and responding to market swings, investors should create a long-term plan founded on sound financial principles. This is true even though real estate is frequently a wise investment in specific situations. Focusing on the fundamentals, such as an asset's potential for long-term growth rather than its immediate price fluctuations, is essential for making wise investment decisions—especially for Charles River Laboratories International employees.

In Conclusion

A clear reminder of how investors continue to mismanage their retirement funds can be found in the Gallup survey. Whether it’s overvaluing gold, placing too much trust in savings accounts and CDs, or repeatedly misjudging the stock market and real estate, these mistakes can have long-term consequences. It’s important to understand that investments should be chosen based on their historical performance and long-term potential, not based on short-term trends or hype. By making informed, rational decisions and sidestepping the pitfalls of buying high and selling low, Charles River Laboratories International employees can better strengthen their financial outlook.

Featured Video

Articles you may find interesting:

Loading...

Sources:

1. Arends, Brett. 'This is How Americans are Blowing Their Retirement Money — Again.' MarketWatch, 20 May 2025,  www.marketwatch.com/retirement-blunders-2025 .

2. Brenan, Megan. 'Stocks Fall, Gold Rises; Real Estate Still Best Investment.' Gallup, 5 May 2025,  www.gallup.com/retirement-investments .

3. Advisor Perspectives Team. 'Gold Gains in Gallup's Latest Poll.' Advisor Perspectives, 18 May 2025,  www.advisorperspectives.com/gallup-gold-investment .

4. CBS News Staff. 'Should Seniors Invest in Gold with the Price So High?' CBS News, 22 May 2025,  www.cbsnews.com/gold-investment .

5. Kiplinger Staff. 'Is Financial Advice From a Professional Worth $8,000?' Kiplinger, 26 May 2025, www.kiplinger.com/financial-advice-worth.

What type of retirement savings plan does Charles River Laboratories International offer?

Charles River Laboratories International offers a 401(k) retirement savings plan to its employees.

Does Charles River Laboratories International match employee contributions to the 401(k) plan?

Yes, Charles River Laboratories International provides a matching contribution to employee 401(k) contributions, subject to certain limits.

What is the eligibility requirement to participate in the 401(k) plan at Charles River Laboratories International?

Employees of Charles River Laboratories International are generally eligible to participate in the 401(k) plan after completing a specified period of service.

How can employees of Charles River Laboratories International enroll in the 401(k) plan?

Employees can enroll in the 401(k) plan through the company’s benefits portal or by contacting the HR department at Charles River Laboratories International.

What investment options are available in the 401(k) plan at Charles River Laboratories International?

Charles River Laboratories International offers a variety of investment options in its 401(k) plan, including mutual funds, target-date funds, and other investment vehicles.

Can employees of Charles River Laboratories International take loans against their 401(k) savings?

Yes, Charles River Laboratories International allows employees to take loans against their 401(k) savings, subject to the plan's rules and regulations.

What is the vesting schedule for employer contributions in the 401(k) plan at Charles River Laboratories International?

The vesting schedule for employer contributions at Charles River Laboratories International may vary, but typically follows a graded vesting schedule over several years.

How often can employees of Charles River Laboratories International change their 401(k) contributions?

Employees can change their 401(k) contribution amounts at any time, subject to the plan's guidelines set by Charles River Laboratories International.

Are there any fees associated with the 401(k) plan at Charles River Laboratories International?

Yes, there may be administrative fees associated with the 401(k) plan at Charles River Laboratories International, which are disclosed in the plan documents.

What resources does Charles River Laboratories International provide to help employees manage their 401(k) investments?

Charles River Laboratories International provides educational resources, access to financial advisors, and online tools to help employees manage their 401(k) investments.

With the current political climate we are in it is important to keep up with current news and remain knowledgeable about your benefits.
Update: In 2024, Charles River Laboratories International has announced a significant overhaul of its 401(k) plan, which includes increasing the company match percentage and introducing a new vesting schedule. This change is aimed at improving employee retention and competitive positioning. The update is crucial in the current economic environment where employees are seeking better retirement benefits amid economic uncertainty.
Restructuring Layoffs: Charles River Laboratories announced a workforce reduction in early 2024. The company is consolidating its facilities and focusing on higher-margin services, resulting in layoffs primarily affecting administrative and support roles. This restructuring is part of their broader strategy to streamline operations and reduce costs amidst economic uncertainty.
Charles River Laboratories International Stock Options and RSUs 2022 Stock Options: Charles River Laboratories International granted stock options primarily to executives and senior management. These options typically had a vesting period of 4 years with annual vesting in 25% increments. RSUs: RSUs were awarded to a broader employee base, including senior executives and key employees. These units generally vested over a period of 3 years with a performance component tied to company goals. Availability: Stock options and RSUs were part of the company's broader compensation package to attract and retain top talent, with specific allocations based on role and performance. 2023 Stock Options: Charles River Laboratories International continued to offer stock options, mainly to higher-level executives and employees in strategic roles. The options typically had a 4-year vesting schedule with performance criteria. RSUs: In 2023, Charles River Laboratories International expanded its RSU program to include mid-level management. The vesting schedule remained similar, with a 3-year timeline and performance metrics. Availability: Both stock options and RSUs were used to incentivize employees and align their interests with company performance, with allocation levels varying by position and individual performance. 2024 Stock Options: For 2024, Charles River Laboratories International maintained its stock option program, focusing on key positions and high performers. The vesting schedule continued to be spread over 4 years. RSUs: The RSU program for 2024 included adjustments to address market conditions and employee retention. The vesting period stayed at 3 years, with an increased emphasis on performance-based criteria. Availability: The stock options and RSUs were integral to the company’s compensation strategy, aimed at rewarding contributions and aligning employee interests with the company’s long-term goals.
Charles River Laboratories International offers a range of health benefits designed to support employee well-being. For the years 2022, 2023, and 2024, the company has implemented comprehensive healthcare coverage including medical, dental, and vision insurance. In 2023, Charles River Laboratories introduced a new Health Savings Account (HSA) option for employees, allowing for more flexible contributions and tax advantages. Additionally, the company provides an Employee Assistance Program (EAP) to support mental health and work-life balance. Recent updates also include enhanced telehealth services and expanded coverage for preventive care. In the current economic and political climate, Charles River Laboratories' healthcare offerings play a crucial role in attracting and retaining talent. As the investment landscape evolves, the company's commitment to comprehensive healthcare benefits helps mitigate employee concerns about medical costs and access to care. This focus on health benefits is particularly relevant amid ongoing discussions about healthcare policy reforms and economic fluctuations, which can impact both corporate budgets and employee well-being. As such, Charles River Laboratories' proactive approach to healthcare is an important factor in maintaining employee satisfaction and organizational stability.
New call-to-action

Additional Articles

Check Out Articles for Charles River Laboratories International employees

Loading...

For more information you can reach the plan administrator for Charles River Laboratories International at 251 Ballardvale St. Wilmington, MA 1887; or by calling them at 1-781-222-6000.

https://www.businessinsider.com/ https://www.reuters.com/ https://www.bloomberg.com/asia https://www.marketwatch.com/ http://www.thelayoff.com/ http://www.sec.gov/ http://www.fidelity.com/ http://www.morningstar.com/ http://www.bloomberg.com/ https://www.thelayoff.com/ https://www.businessinsider.com/ https://www.reuters.com/ https://www.bloomberg.com/asia

*Please see disclaimer for more information

Relevant Articles

Check Out Articles for Charles River Laboratories International employees